Archives

 

European Commission Horizon 2020 – application rejected

The European Commission, EC, has rejected Emotra’s application, submitted in January 2017, for approximately 3 MEUR, intended for three purposes: First of all to finance EUDOR-Y, a clinical multi-centre study on young people, secondly to develop EDOR® Interconnect, and thirdly to further develop our hardware and software solutions. Similar to last time, the application cleared […]

Emotra AB (publ) Year-end report January 1 – December 31, 2016

The Board and CEO of Emotra AB herewith present the year-end report for the financial year 2016.   170215 – Year-end report 2016    

Emotra has submitted a new application for a grant from the EU Horizon 2020 programme

Emotra has submitted a new application to the European Commission (EC) for Horizon 2020 funding assistance. The Company’s previous application, which we submitted in October 2016, cleared the threshold by a wide margin and was awarded a “Seal of Excellence” by the EC. The Company is now focused on our planned, international market launch. Emotra’s […]

Emotra’s application is given the “Seal of Excellence”

On November 28, Emotra announced that the Company’s Horizon 2020 application to the European Commission has been rejected. We have now had the opportunity to review the EC’s statement and we see that our application passed their threshold by a wide margin and that it was given a “Seal of Excellence”.   161130-emotra-nyhetsbrev-emotra-seal-of-excellence_en

Future report dates for Emotra

Emotra’s Board of Directors has decided the following dates for release of financial reports and the annual shareholder meeting   161128-emotra-nyhetsbrev-dates-for-financial-reports-en

European Commission Horizon 2020 – application rejected

The European Commission has rejected Emotra’s application for approximately 3 MEUR, which we intended to use for three purposes: First of all to finance EUDOR-Y, a clinical multi-centre study on young people, secondly to develop EDOR® Interconnect, and thirdly to further develop our hardware and software solutions. Emotra has not yet had the opportunity to […]

Emotra – Lars-Håkan Thorell held presentation in Chicago

Last week in Chicago, Lars-Håkan Thorell, the inventor of EDOR® and the Company’s Head of research, held a presentation that gathered a great deal of attention. He presented the result of his research and how it led to the development of EDOR®. 161031-emotra-news-letter-thorell-presented-in-chicago

Emotra AB (publ)Interim report January 1 – September 30, 2016

The Board of Directors and the CEO of Emotra AB (publ) hereby present the interim report for the first nine months of the financial year 2016. 161026-interim-report-jan-sept-2016

Emotra – Lars-Håkan Thorell praised by ECNP

This past week Lars-Håkan Thorell, the inventor of EDOR® and Emotra’s Head of research, has received a great deal of attention for his many years of research into identifying patients who are at risk of committing suicide. Thorell has been voted in as a member of the European College of Neuropsychopharmacology, ECNP. On Tuesday, September […]

A short update – Successful meetings for Emotra in Oviedo

During the past few days, on September 8–11, Emotra participated in the 16th European Symposium on Suicide and Suicidal Behaviour, ESSSB, in Oviedo, Spain. New, exciting studies on EDOR® were presented by research groups from Oviedo and Novara.   160913-emotra-newsletter-successful-convention-in-oviedo